rewirebio.iobenchmarks
Configuration

STAR-Fusion v1.10.0 (Tamura et al. 2026)

STAR-Fusion as run in the cited comparison.

4 evaluations · 24 results

Overview

STAR-Fusion as run in the cited comparison.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

4 evaluations · 24 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.39 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1,039 false-negative-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1,061 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.39 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.39 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
678 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.47 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
117 false-negative-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
76 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.53 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.43 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
87 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.97 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
4 false-negative-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.93 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
57 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.96 f1-score
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'F1' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
2 false-negative-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False negative' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0 false-positive-count
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'False positive' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
1 precision
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'Positive predictive value' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.92 recall
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive rate' (PDF page text)
Configuration: STAR-Fusion v1.10.0 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
22 true-positive-count
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

STAR-Fusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'STAR-Fusion', column 'True positive' (PDF page text)

Source checking is not independent reproduction. Release 2026-10-09-ba02f2f4a36e.

Use this model

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-09-ba02f2f4a36e
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-09-ba02f2f4a36e · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: rna-fusion-20261009-config-tamura2026-star-fusion

areas
rna-transcriptomes
contexts
clinical_research
method types
conventional_pipeline
reported name
STAR-Fusion
version
v1.10.0
foundation model eligible
false
protocol
Default parameters; alignment method STAR; aligner STAR v2.7.8a; GRCh38; filtered output used where available
source locator
Supplementary Table 1; Methods 'Detection of gene fusions by each algorithm'
Related records

Suggest a correction